BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21920407)

  • 21. Rock2 controls TGFbeta signaling and inhibits mesoderm induction in zebrafish embryos.
    Zhang Y; Li X; Qi J; Wang J; Liu X; Zhang H; Lin SC; Meng A
    J Cell Sci; 2009 Jul; 122(Pt 13):2197-207. PubMed ID: 19509062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. km23: a novel TGFbeta signaling target altered in ovarian cancer.
    Ding W; Mulder KM
    Cancer Treat Res; 2004; 119():315-27. PubMed ID: 15164884
    [No Abstract]   [Full Text] [Related]  

  • 23. Requirement of TGFbeta signaling for SMO-mediated carcinogenesis.
    Fan Q; He M; Sheng T; Zhang X; Sinha M; Luxon B; Zhao X; Xie J
    J Biol Chem; 2010 Nov; 285(47):36570-6. PubMed ID: 20858897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling.
    Nyati S; Schinske K; Ray D; Nyati MK; Ross BD; Rehemtulla A
    Clin Cancer Res; 2011 Dec; 17(23):7424-39. PubMed ID: 21948232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGFβ (transforming growth factor β) and keratocyte motility in 24 h zebrafish explant cultures.
    Tan B; Pascual A; de Beus A; Cooper K; Hull E
    Cell Biol Int; 2011 Nov; 35(11):1131-9. PubMed ID: 21729005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Roadblock light chains are ubiquitous components of cytoplasmic dynein that form homo- and heterodimers.
    Nikulina K; Patel-King RS; Takebe S; Pfister KK; King SM
    Cell Motil Cytoskeleton; 2004 Apr; 57(4):233-45. PubMed ID: 14752807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
    Wang J; Han W; Zborowska E; Liang J; Wang X; Willson JK; Sun L; Brattain MG
    J Biol Chem; 1996 Jul; 271(29):17366-71. PubMed ID: 8663343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGFbeta receptor independent manner.
    Parker WL; Goldring MB; Philip A
    J Bone Miner Res; 2003 Feb; 18(2):289-302. PubMed ID: 12568406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynein/dynactin is necessary for anterograde transport of
    Herbert AL; Fu MM; Drerup CM; Gray RS; Harty BL; Ackerman SD; O'Reilly-Pol T; Johnson SL; Nechiporuk AV; Barres BA; Monk KR
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):E9153-E9162. PubMed ID: 29073112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactome of transforming growth factor-beta type I receptor (TbetaRI): inhibition of TGFbeta signaling by Epac1.
    Conrotto P; Yakymovych I; Yakymovych M; Souchelnytskyi S
    J Proteome Res; 2007 Jan; 6(1):287-97. PubMed ID: 17203972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trk activation of the ERK1/2 kinase pathway stimulates intermediate chain phosphorylation and recruits cytoplasmic dynein to signaling endosomes for retrograde axonal transport.
    Mitchell DJ; Blasier KR; Jeffery ED; Ross MW; Pullikuth AK; Suo D; Park J; Smiley WR; Lo KW; Shabanowitz J; Deppmann CD; Trinidad JC; Hunt DF; Catling AD; Pfister KK
    J Neurosci; 2012 Oct; 32(44):15495-510. PubMed ID: 23115187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follicle-restricted compartmentalization of transforming growth factor beta superfamily ligands in the feline ovary.
    Bristol SK; Woodruff TK
    Biol Reprod; 2004 Mar; 70(3):846-59. PubMed ID: 14656728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zili inhibits transforming growth factor-beta signaling by interacting with Smad4.
    Sun H; Li D; Chen S; Liu Y; Liao X; Deng W; Li N; Zeng M; Tao D; Ma Y
    J Biol Chem; 2010 Feb; 285(6):4243-4250. PubMed ID: 20007318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGFβ-induced PI 3 kinase-dependent Mnk-1 activation is necessary for Ser-209 phosphorylation of eIF4E and mesangial cell hypertrophy.
    Das F; Ghosh-Choudhury N; Bera A; Kasinath BS; Choudhury GG
    J Cell Physiol; 2013 Jul; 228(7):1617-26. PubMed ID: 23359369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase.
    Pulipati NR; Jin Q; Liu X; Sun B; Pandey MK; Huber JP; Ding W; Mulder KM
    Int J Cancer; 2011 Aug; 129(3):553-64. PubMed ID: 21469138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the TGFβ Pathway Enhances Retinal Regeneration in Adult Zebrafish.
    Tappeiner C; Maurer E; Sallin P; Bise T; Enzmann V; Tschopp M
    PLoS One; 2016; 11(11):e0167073. PubMed ID: 27880821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CIN85 modulates TGFβ signaling by promoting the presentation of TGFβ receptors on the cell surface.
    Yakymovych I; Yakymovych M; Zang G; Mu Y; Bergh A; Landström M; Heldin CH
    J Cell Biol; 2015 Jul; 210(2):319-32. PubMed ID: 26169354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
    Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
    PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.